Erik L. Ridley and Philip Ward

AI
RadNet broadens AI focus with acquisitions of Aidence, Quantib
U.S. imaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.
January 23, 2022
2021 07 16 16 27 9194 Artificial Intelligence Ai Abstract 400
Page 1 of 1
Top Stories
Brain Stroke
Patient Safety
CDSS improves outcomes among stroke patients
Use of a clinical decision-support system (CDSS) with stroke sufferers decreased the incidence of new vascular events at three months.
Business Green Environment World
Organized Radiology Issues
Radiology's carbon problem needs more than good intentions
Breast Cancer 3 D 400
Womens Imaging
Mammography AI approach finds more breast cancers, reduces workload
Europe Data Resized
Imaging Informatics
Making data speak the same language: Harmonization and health data
Thérèse Herlihy, PhD, at ECR 2026 discusses the state of radiographer-performed POCUS and what's needed for expanded scope of practice.
Ultrasound
Training, standards needed for radiographers to perform POCUS
More in Home
CDSS improves outcomes among stroke patients
By Kate Madden Yee
Use of a clinical decision-support system (CDSS) with stroke sufferers decreased the incidence of new vascular events at three months.
March 20, 2026
Brain Stroke
Radiology's carbon problem needs more than good intentions
By Claudia Tschabuschnig
Healthcare generates 4.4% of global emissions. Radiology accounts for a notable slice. At ECR 2026, three perspectives on the same problem showed exactly why change is slow and where the real leverage is.
March 20, 2026
Business Green Environment World
Mammography AI approach finds more breast cancers, reduces workload
By Amerigo Allegretto
An AI approach that excludes low-risk mammograms from radiologist reading led to more cancers being found.
March 19, 2026
Breast Cancer 3 D 400
Making data speak the same language: Harmonization and health data
By Claudia Tschabuschnig
Europe's imaging data is vast, fragmented, and increasingly powerful. Two sessions at ECR 2026 asked the same question from opposite ends: How do you make it usable?
March 19, 2026
Europe Data Resized
Training, standards needed for radiographers to perform POCUS
By Amerigo Allegretto
Training, standardization, and careful management are needed for radiographers to regularly use point-of-care ultrasound (POCUS) in imaging departments.
March 19, 2026
Thérèse Herlihy, PhD, at ECR 2026 discusses the state of radiographer-performed POCUS and what's needed for expanded scope of practice.
Radiographer judgment still essential in AI-assisted x-ray
By Maryam Payne
While AI by itself performed well, it lagged behind the radiographers using AI.
March 18, 2026
Radiologist Xray Foot 400
Researchers optimistic on healthcare AI privacy risk fixes
By Maryam Payne
Privacy concerns with healthcare foundation models (FMs) can be mitigated through safeguards embedded into FM design.
March 16, 2026
Privacy Keyboard 400
EAU: Experts highlight imaging advances in prostate cancer screening
By Kate Madden Yee
The European Association of Urology (EAU) is touting four studies that demonstrate the advancement of prostate cancer screening.
March 16, 2026
Prostate Cancer Rendering
MRI biomarkers poised to reshape multiple sclerosis management
By Liz Carey
Various methods have been proposed to quantify myelin alone.
March 13, 2026
Yukio Miki, MD, PhD.
When AI and radiologists miss the same thing
By Claudia Tschabuschnig
One session at ECR 2026 took a deeper look at the hidden layers behind medical AI: biased datasets, human perception, automation errors, and the fragile trust between radiologists and machines.
March 13, 2026
Dr. Martin Willemink, PhD.
GE highlights new CT, molecular imaging scanners at ECR 2026
By Erik L. Ridley
A new photon-counting scanner and two molecular imaging systems were among the highlights for GE HealthCare at ECR 2026.
March 12, 2026
Ge Hc Logo
Identifying CAD risk over time: A SCOT-HEART trial analysis
By Maryam Payne
One-third of patients with initially normal CCTA imaging developed CAD during the SCOT-HEART study’s 10-year follow-up period.
March 12, 2026
Development of CAD in a 43-year-old male smoker, with atypical chest pain, hypercholesterolemia, and a family history of CAD. At baseline, the coronary artery calcium score was zero (A), and the coronary CT angiogram was normal (B). Noncontrast CT chest (C) 10 years later showed calcified plaques in the right coronary artery and left circumflex coronary artery.
Page 1 of 76
Next Page